Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPOC Proteomics has developed a proprietary biosensor chip platform that enables the simultaneous production and kinetic analysis of thousands of full-length folded proteins. This dramatically reduces the cost and increases the throughput of surface plasmon resonance (SPR)-based protein binding assays, supporting drug discovery, AI-driven drug design validation, biomarker discovery, diagnostics development, and synthetic biology applications. Their chips are being used by large biopharma companies and AI drug design firms to accelerate preclinical research at scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPOC Proteomics.